跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ICATIBANTO CIPLA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ICATIBANTO CIPLA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Approved
STANDARD
ICATIBANTO CIPLA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Cipla Europe N.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 14, 2022
Approval ID
01ebb5bf3b75e2ab
Company
Cipla Europe N.V.
Type
Standard
Approval Details
Approval Id
01ebb5bf3b75e2ab
Drug Cima Aemps Name
ICATIBANTO CIPLA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Register Number
86564
Holder Company Name
Cipla Europe N.V.
Marketing Company Name
Cipla Europe Nv Sucursal En Espana
Authorization Date
2022-02-14
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
30 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Cipla Europe N.V.
Active Ingredients
ICATIBANTO ACETATO
35,52 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 14, 2022
Approval ID
01ebb5bf3b75e2ab
Type
Standard
Back to CIMA-AEMPS Approvals